These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 3856076)

  • 21. Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies.
    Yoshikawa T; Nishida K; Tanigawa M; Fukumoto K; Kondo M
    Digestion; 1985; 31(2-3):67-76. PubMed ID: 2581838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer.
    Marrelli D; Pinto E; De Stefano A; Farnetani M; Garosi L; Roviello F
    Am J Surg; 2001 Jan; 181(1):16-9. PubMed ID: 11248169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer.
    Safi F; Kuhns V; Beger HG
    Int J Biol Markers; 1995; 10(2):100-6. PubMed ID: 7561233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences.
    Barillari P; Sammartino P; Cardi M; Ricci M; Gozzo P; Cesareo S; Cerasi A
    Aust N Z J Surg; 1991 Sep; 61(9):675-80. PubMed ID: 1877936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experiences with determining carcinoembryonic antigen in tumors of the digestive tract].
    Pelikán A
    Zentralbl Chir; 1986; 111(18):1113-8. PubMed ID: 3024422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers.
    Andriulli A; Gindro T; Piantino P; Farini R; Cavallini G; Piazzi L; Naccarato R; Dobrilla G; Verme G; Scuro LA
    Digestion; 1986; 33(1):26-33. PubMed ID: 3940235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
    Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
    Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The doubling time of circulating CEA as an individual prognostic criterion of recurrence in patients with gastrointestinal cancers].
    Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
    Klin Wochenschr; 1986 Jan; 64(2):63-9. PubMed ID: 3951166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoembryonic antigen slope analysis as an early indicator for recurrence of colorectal carcinoma.
    Kimura O; Kaibara N; Nishidoi H; Okamoto T; Takebayashi M; Kawasumi H; Koga S
    Jpn J Surg; 1986 Mar; 16(2):106-11. PubMed ID: 3723883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical usefulness of three monoclonal antibody-defined tumor markers: CA 19-9, CA 50, and CA 125.
    Szymendera JJ
    Tumour Biol; 1986; 7(5-6):333-42. PubMed ID: 2437641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
    Staab HJ; Hornung A; Anderer FA; Kieninger G
    Dtsch Med Wochenschr; 1984 Jul; 109(30):1141-7. PubMed ID: 6204834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of the new tumor marker TAG-72.
    Guadagni F; Roselli M; Ferroni P; Amato T; Colcher D; Greiner JW; Schlom J
    Anticancer Res; 1991; 11(4):1389-94. PubMed ID: 1746895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer.
    Benini L; Cavallini G; Zordan D; Rizzotti P; Rigo L; Brocco G; Perobelli L; Zanchetta M; Pederzoli P; Scuro LA
    Pancreas; 1988; 3(1):61-6. PubMed ID: 3163149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
    Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
    Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
    Kuusela P; Haglund C; Roberts PJ; Jalanko H
    Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
    Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
    Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.